Valaciclovir

Product Name: Valaciclovir
CAS No.: 124832-26-4
Chemical Name: Valaciclovir
Synonyms: VALACYCLOVIR;VALACICLOVIR HYDROCHLORIDE;VALACICLOVIR HCL;VALACV;256U87;Valcivir;VALACICLOVIR;100MG/1G/1KG;Valacyclovir-d4;ValaciclovirBase
CBNumber: CB2379191
Molecular Formula: C13H20N6O4
Formula Weight: 324.34
MOL File: 124832-26-4.mol

More

Less

Valaciclovir Property

Density: 1.55±0.1 g/cm3(Predicted)
storage temp.: Store at -20°C
solubility: Soluble in DMSO
form: Powder
pka: 9.34±0.20(Predicted)
EPA Substance Registry System: L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester (124832-26-4)

More

Less

Safety

Hazard Codes: Xi
Risk Statements: 36/37/38
Safety Statements: 26-36
Hazardous Substances Data: 124832-26-4(Hazardous Substances Data)

More

Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Warning

Hazard statements

H302Harmful if swallowed

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P330Rinse mouth.

P501Dispose of contents/container to..…

More

Less

N-Bromosuccinimide Price

ApexBio Technology

Product number: A3903
Product name: Valaciclovir
Packaging: 10mg
Price: $71
Updated: 2021/12/16

ApexBio Technology

Product number: A3903
Product name: Valaciclovir
Packaging: 50mg
Price: $110
Updated: 2021/12/16

Biorbyt Ltd

Product number: orb611674
Product name: Valacyclovir
Packaging: 100mg
Price: $277.1
Updated: 2021/12/16

Biorbyt Ltd

Product number: orb134346
Product name: Valaciclovir HCl
Purity: >99%
Packaging: 100mg
Price: $510
Updated: 2021/12/16

Biorbyt Ltd

Product number: orb611674
Product name: Valacyclovir
Packaging: 1g
Price: $615.4
Updated: 2021/12/16

More

Less

Valaciclovir Chemical Properties,Usage,Production

Description

Valaciclovir (also known as BW256U87 or valaciclovir, and marketed under the trade name of Valtrexs by GlaxoSmithKline) is the hydrochloride salt of the L-valyl ester of aciclovir that was developed originally by Wellcome Research Laboratories. This aciclovir prodrug is rapidly and virtually completely converted to aciclovir following oral administration. As oral administration of valaciclovir results in aciclovir plasma levels nearly equivalent to those achieved by intravenous administration, its efficacy is superior to that of oral aciclovir for the treatment of zoster and equivalent to oral aciclovir in the treatment of first and recurrent episodes of genital herpes.

Chemical Properties

White Solid

Originator

Valcivir,Cipla Limited

Uses

The L-Valine ester prodrug of Acyclovir.

Valacyclovir (Valtrex) is the 1-valine ester (prodrug) of acyclovir that exhibits no activity until hydrolyzed in the intestinal wall or liver to acyclovir and its active metabolite. Its modified structure allows increased intestinal absorption and concomitant higher plasma levels of acyclovir. It demonstrates activity against HSV types 1 and 2, varicella-zoster virus, and cytomegalovirus. It exerts its effects by interfering with DNA synthesis through phosphorylation by viral thymidine kinase and subsequent inhibition of viral DNA polymerase, thereby inhibiting viral replication. Valtrex is indicated for the treatment of acute herpes zoster and recurrent genital herpes in immunocompetent adults. The most common side effects are headache, nausea, and vomiting.

Indications

Valacyclovir (Valtrex) is the 1-valine ester (prodrug) of acyclovir that exhibits no activity until hydrolyzed in the intestinal wall or liver to acyclovir and its active metabolite. Its modified structure allows increased intestinal absorption and concomitant higher plasma levels of acyclovir. It demonstrates activity against HSV types 1 and 2, varicella-zoster virus, and cytomegalovirus. It exerts its effects by interfering with DNA synthesis through phosphorylation by viral thymidine kinase and subsequent inhibition of viral DNA polymerase, thereby inhibiting viral replication. Valtrex is indicated for the treatment of acute herpes zoster and recurrent genital herpes in immunocompetent adults. The most common side effects are headache, nausea, and vomiting.
Valacyclovir is the only antiviral agent approved for herpes labialis, for a 3-day course in the episodic treatment of recurrent genital herpes (2). Valacyclovir is indicated for recurrent genital herpes and is administered at 500 mg twice daily for 3 days at the onset of prodromal symptoms or at the first sign of infection.

Definition

ChEBI: Valacyclovir is a L-valyl ester. It has a role as an antiviral drug. It is functionally related to a guanine.

Manufacturing Process

By dicyclohexylcarbodiimide catalyzed esterification of acyclovir (6H-purin-6- one, 1,9-dihydro-2-amino-9-((2-hydroxyethoxy)methyl)-) with the butyloxycarbonyl valine. Treatment of ester obtained with trifluoroacetic acid leads to scission of the BOC group to provide L-valine ester with 9-((2- hydroxyethoxy)methyl)guanine (valacyclovir).

brand name

Valtrex (GlaxoSmithKline).

Therapeutic Function

Antiviral

Biological Activity

valacyclovir, the metabolic precursor of , is now approved for treatment and prevention of genital infection with herpes simplex viruses [1]. in vitro: vacv uptake was concentration dependent and saturable with a michaelis-menten constant and maximum velocity of 1.64 +/- 0.06 mm and 23.34 +/- 0.36 nmol/mg protein/5 min, respectively. a very similar km value was obtained in hpept1/cho cells and in rat and rabbit tissues and caco-2 cells, suggesting that hpept1 dominates the intestinal transport properties of vacv in vitro [5].

Pharmacology

Valacyclovir (Valtrex), a valine ester prodrug of acyclovir, has a bioavailability three to five times that of acyclovir. This is due to its improved gastrointestinal absorption compared to acyclovir. Valacyclovir is rapidly and almost completely converted to acyclovir after oral administration, with levels comparable to those of intravenous acyclovir. This allows for twice-daily dosing, which may improve compliance and ultimate clinical efficacy. It is more costly than acyclovir.

Clinical Use

Antiviral:
Herpes zoster and simplex
Prevention of cytomegalovirus (CMV) disease after renal transplantation

in vivo

for treatment of a first episode of genital herpes, a large comparative trial has shown that valacyclovir (1 g twice a day) is as effective as acyclovir (200 mg five times a day) when given for 10 days. for treating recurrences, two trials show that valacyclovir is as effective as acyclovir (200 mg five times a day) with a treatment period of 5 days. a daily dose of 1 g of valacyclovir is as effective as 2 g daily. valacyclovir can be administered once a day[1]. the concentrations of acyclovir in serum and csf were measured at steady state after 6 days of oral treatment with 1,000 mg of valacyclovir three times a day [2]. ec50 values of pe and ac in 3t3 cells were 0.02 and 0.01 ug/ml, while values in bhk cells were 0.2 and 0.03 ug/ml. treatment of infected immunosuppressed mice and fa and va (b.i.d., 5.5 days) reduced the proportion with erythema from 100% to 24% and 38%, and eliminated ear paralysis, ear lesions (vesicles, etc) and death. virus was absent from ear and brainstem by day 6, but reappeared after discontinuation in mice treated with va [3].

Drug interactions

Potentially hazardous interactions with other drugs
Ciclosporin: may alter ciclosporin levels; possibly increased risk of nephrotoxicity.
Mycophenolate: higher concentrations of both aciclovir and mycophenolic acid on concomitant administration.
Tacrolimus: possibly increased risk of nephrotoxicity

IC 50

value: 2.9 microg/ml (for hsv-1 w)[4]. valacyclovir, the metabolic precursor of , is now approved for treatment and prevention of genital infection with herpes simplex viruses [1]. in vitro: vacv uptake was concentration dependent and saturable with a michaelis-menten constant and maximum velocity of 1.64 +/- 0.06 mm and 23.34 +/- 0.36 nmol/mg protein/5 min, respectively. a very similar km value was obtained in hpept1/cho cells and in rat and rabbit tissues and caco-2 cells, suggesting that hpept1 dominates the intestinal transport properties of vacv in vitro [5]. in vivo: for treatment of a first episode of genital herpes, a large comparative trial has shown that valacyclovir (1 g twice a day) is as effective as acyclovir (200 mg five times a day) when given for 10 days. for treating recurrences, two trials show that valacyclovir is as effective as acyclovir (200 mg five times a day) with a treatment period of 5 days. a daily dose of 1 g of valacyclovir is as effective as 2 g daily. valacyclovir can be administered once a day[1]. the concentrations of acyclovir in serum and csf were measured at steady state after 6 days of oral treatment with 1,000 mg of valacyclovir three times a day [2]. ec50 values of pe and ac in 3t3 cells were 0.02 and 0.01 ug/ml, while values in bhk cells were 0.2 and 0.03 ug/ml. treatment of infected immunosuppressed mice and fa and va (b.i.d., 5.5 days) reduced the proportion with erythema from 100% to 24% and 38%, and eliminated ear paralysis, ear lesions (vesicles, etc) and death. virus was absent from ear and brainstem by day 6, but reappeared after discontinuation in mice treated with va [3].

Metabolism

Valaciclovir is readily absorbed from the gastrointestinal tract after oral doses, and is rapidly and almost completely converted to aciclovir and valine by first-pass intestinal or hepatic metabolism.
Aciclovir is converted to a small extent to the metabolites 9(carboxymethoxy)methylguanine (CMMG) by alcohol and aldehyde dehydrogenase and to 8-hydroxy-aciclovir (8-OH-ACV) by aldehyde oxidase. Approximately 88
% of the total combined plasma exposure is attributable to aciclovir, 11
% to CMMG and 1
% to 8-OH-ACV. Valaciclovir is eliminated mainly as aciclovir and its metabolite 9- CMMG; less than 1
% of a dose of valaciclovir is excreted unchanged in the urine.

Toxicity evaluation

In general, the adverse reactions with valaciclovir are similar to those seen with its active metabolite, aciclovir. Preclinical toxicology studies with valaciclovir toxicology studies in animals showed no toxicity separate to that expected from the active metabolite. In a phase 1 study of valaciclovir dosed at either 1 or 2 g four times daily for 30 days, the main reported side-effects were gastrointestinal, with nausea, vomiting, diarrhea, and abdominal pain in up to onethird of patients; no renal or neurologic side-effects were notetoxd, but four patients developed grade 3 or 4 neutropenia. None of the sideeffects observed appeared to be drug related.

Valaciclovir Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Valaciclovir Suppliers

Canada 2 China 158 Europe 2 Germany 3 India 13 Italy 1 South Korea 1 Switzerland 1 United Kingdom 9 United States 37 Global 227

LGM Pharma

Tel: 1-(800)-881-8210
Fax: 615-250-9817
Email: inquiries@lgmpharma.com
Country: United States
ProdList: 2123
Advantage: 70

MedChemexpress LLC

Tel: 021-58955995
Fax: 609-228-5909
Email: sales@medchemexpress.cn
Country: United States
ProdList: 4861
Advantage: 58

BOC Sciences

Tel: 16314854226
Email: info@bocsci.com
Country: United States
ProdList: 9923
Advantage: 65

Musechem

Tel: +1-800-259-7612
Fax: +1-800-259-7612
Email: info@musechem.com
Country: United States
ProdList: 4660
Advantage: 60

TargetMol Chemicals Inc.

Tel
Email: support@targetmol.com
Country: United States
ProdList: 38631
Advantage: 58

TargetMol Chemicals Inc.

Tel: +8613564774135
Email: zijue.cai@tsbiochem.com
Country: United States
ProdList: 19884
Advantage: 58

Protheragen-ING

Tel: +16313385890
Email: info@protheragen-ing.com
Country: United States
ProdList: 3868
Advantage: 58

ApexBio Technology

Tel: --
Fax: --
Email: sales@apexbt.com
Country: United States
ProdList: 6251
Advantage: 58

United States Biological

Tel: --
Fax: --
Email: sales@advtechind.com
Country: United States
ProdList: 6075
Advantage: 58

EJY Tech, Inc.

Tel: --
Fax: --
Country: United States
ProdList: 448
Advantage: 30

3B Scientific Corporation

Tel: --
Fax: --
Email: sales@3bsc.com
Country: United States
ProdList: 6962
Advantage: 56

United States Biological

Tel: --
Fax: --
Email: chemicals@usbio.net
Country: United States
ProdList: 6214
Advantage: 80

MedChemExpress

Tel: --
Fax: --
Email: sales@medchemexpress.com
Country: United States
ProdList: 6398
Advantage: 58

Combi-Blocks Inc.

Tel: --
Fax: --
Email: sales@combi-blocks.com
Country: United States
ProdList: 6618
Advantage: 69

CacheSyn Inc.

Tel: --
Fax: --
Email: info@cachesyn.com
Country: United States
ProdList: 695
Advantage: 50

AlliChem, LLC

Tel: --
Fax: --
Email: sales@allichemllc.com
Country: United States
ProdList: 6516
Advantage: 60

Labseeker Inc

Tel: --
Fax: --
Email: marketing@labseeker.com
Country: United States
ProdList: 1495
Advantage: 55

Cerilliant Corporation

Tel: --
Fax: --
Email: techserv@cerilliant.com
Country: United States
ProdList: 1629
Advantage: 69

ACIC Fine Chemicals Inc.

Tel: --
Fax: --
Email: sales@acic.com
Country: United States
ProdList: 492
Advantage: 48

Beta Pharma, Inc.

Tel: --
Fax: --
Email: sales@betapharma.com
Country: United States
ProdList: 6226
Advantage: 60

Waterstone Technology, LLC

Tel: --
Fax: --
Email: sales@waterstonetech.com
Country: United States
ProdList: 6786
Advantage: 30

Altan Corporation

Tel: --
Fax: --
Email: OrderingService@AltanBiochemicals.com
Country: United States
ProdList: 1161
Advantage: 30

2A PharmaChem USA

Tel: --
Fax: --
Email: sales@2apharmachem.com
Country: United States
ProdList: 6137
Advantage: 39

3B Scientific Corporation

Tel: --
Fax: --
Email: sales@3bsc.com
Country: United States
ProdList: 6718
Advantage: 47

HONEST JOY HOLDINGS LIMITED

Tel: --
Fax: --
Email: sales@honestjoy.cn
Country: United States
ProdList: 6675
Advantage: 54

AK Scientific, Inc.

Tel: --
Fax: --
Email: sales@aksci.com
Country: United States
ProdList: 6347
Advantage: 65

SynFine Research

Tel: --
Fax: --
Email: research@synfine.com
Country: United States
ProdList: 1024
Advantage: 68

AvaChem Scientific LLC

Tel: --
Fax: --
Email: Info@avachem.com
Country: United States
ProdList: 315
Advantage: 30

LKT Laboratories, Inc.

Tel: --
Fax: --
Email: info@lktlabs.com
Country: United States
ProdList: 2164
Advantage: 64

Sinova Inc.

Tel: --
Fax: --
Email: sales@sinovainc.com
Country: United States
ProdList: 4009
Advantage: 58

CGeneTech, Inc.

Tel: --
Fax: --
Email: qyu@cgenetech.com
Country: United States
ProdList: 959
Advantage: 30

American Custom Chemicals Corporation

Tel: --
Fax: --
Email: sales@acccorporation.com
Country: United States
ProdList: 6820
Advantage: 51

BOSCHE SCIENTIFIC, LLC

Tel: --
Fax: --
Email: Sales@BoscheSci.com
Country: United States
ProdList: 6477
Advantage: 55

Ennova MedChem Group Inc., formerly Arch Corporation

Tel: --
Fax: --
Email: sales@ennovamedchem.com
Country: United States
ProdList: 1218
Advantage: 42

Aceto Corporation

Tel: --
Fax: --
Email: contact@aceto.com
Country: United States
ProdList: 2619
Advantage: 75

ChemPacific Corporation

Tel: --
Fax: --
Email: sales@chempacific.com
Country: United States
ProdList: 6891
Advantage: 51

Moravek Biochemicals, Inc.

Tel: --
Fax: --
Email: moravek@worldnet.att.net
Country: United States
ProdList: 1227
Advantage: 69

More

Less

View Lastest Price from Valaciclovir manufacturers

Sinoway Industrial co., ltd.

Product: Valaciclovir 124832-26-4
Price: US $0.00-0.00/kg
Min. Order: 1kg
Purity: 99%
Supply Ability: 20TONS
Release date: 2024-09-12

Wuhan Senwayer Century Chemical Co.,Ltd

Product: Valaciclovir 124832-26-4
Price: US $580.00/KG
Min. Order: 1KG
Purity: 99% min
Supply Ability: 20 TONS
Release date: 2022-10-14

Shaanxi Dideu Medichem Co. Ltd

Product: Valaciclovir 124832-26-4
Price: US $0.01-1.00/KG
Min. Order: 1KG
Purity: 99%min
Supply Ability: 20 tons
Release date: 2020-05-08

124832-26-4, ValaciclovirRelated Search:

Trinexapac-ethyl Tris(trimethylsilyl)phosphate 4-Methoxybenzylchloride Methoxydiethylborane 2-Ethoxyethanol p-Anisidine p-Anisaldehyde Ethylparaben p-(2-Methoxyethyl) phenol Valacyclovir hydrochloride (Trifluoromethoxy)benzene Anisole Valine Dimethyl succinate 4-(Trifluoromethoxy)aniline Ethanol ISOXADIFEN-ETHYL L-Valine Valacyclovir

Valaciclovir & Valaciclovir Hydrochloride

Valacyclovir-d4

L-VALINE 2-[(2-AMINO-1,6-DIHYDRO-6-OXO-9H-PURIN-9YL)METHOXY]ETHYL ESTER

L-VALINE 2-[(2-AMINO-1,6-DIHYDRO-6-OXO-9H-PURIN-9YL)METHOXY]ETHYL ESTER, HYDROCHLORIDE SALT

l-valine 2-(guanin-9-ylmethoxy)ethyl ester

VALACICLOVIR

VALACICLOVIR HCL

VALACICLOVIR HYDROCHLORIDE

VALACV

VALACYCLOVIR

VALACICLOVIR 99+%

ValaciclovirBase

Valaciclovir Hydrochloride 124832-27-5 / Base

256U87

L-Valine ester with 9-[(2-hydroxyethoxy)methyl]guanine

L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester (9CI)

100MG/1G/1KG

Valcivir

Valacyclovir Hydrochloride Hydrate (L-Valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-ylmethoxy)ethyl Ester Hydrochloride hydrate

Valaciclovir USP/EP/BP

ValacyclovirQ: What is Valacyclovir Q: What is the CAS Number of Valacyclovir Q: What is the storage condition of Valacyclovir Q: What are the applications of Valacyclovir

124832-26-4

C13H20N6O4

C13H12N6O4D8HCl

C13H20N6O4HCl